Work

Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation

FWCI: 5.033
Cites: 22
Cited by: 38
Related to: 10